SMS Lifesciences
SMS Lifesciences, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in India. Founded in 2006, the company has established a strong presence in key operational regions, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. With a commitment to quality and innovation, SMS Lifesciences offers a diverse range of products that cater to various therapeutic areas, including oncology and cardiology. Their unique approach to research and development has positioned them as a trusted partner in the global market. Notable achievements include compliance with international regulatory standards, which underscores their dedication to excellence. As SMS Lifesciences continues to expand its footprint, it remains a vital contributor to the advancement of healthcare solutions.
DitchCarbon Score
How does SMS Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SMS Lifesciences's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SMS Lifesciences's reported carbon emissions
SMS Lifesciences, headquartered in India, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that SMS Lifesciences has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly prioritises sustainability, SMS Lifesciences may benefit from establishing clear climate commitments and reduction targets to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SMS Lifesciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
